Clinical Trial Update: This Study Tests How BI 754111 is Distributed in Patients With Advanced Non-small Cell Lung Cancer or Patients With Head and Neck Cancer Who Are Treated With BI 754091 [Phase 1]

View source ↗

Summary

This Phase 1 study assesses how BI-754111 is distributed in patients with advanced non-small cell lung cancer or head and neck cancer who are treated with BI-75…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• BI-754091
• BI-754111

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms | Phase 1 | Status: TERMINATED | Results posted: 2026-01-13